When might these drugs become available? Not for several years: they still need to go through large (Phase III) trials, and problems could be found in these larger trials that would kill the development of one or more of the SGLT2 inhibitors. But assuming that the Phase III trials succeed, we can expect that sometime in the future, the next class of diabetes drugs will be the SGLT2 inhibitors.
< Previous 1 | Page 2 >
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse
What the community is saying...
Salivary testing for diabetes
Posted 05/17 Comments (2)
An intriguing abstract was presented at the recent...
